EZZ Life Science Holdings

EZZ flexes China growth strategy with JD Health deal. #ASX #Health $EZZ @EZZLifeScience buff.ly/qQXwKAP

@EZZLifeScience Celebrating 5 years as a listed company! Proud of our journey and excited for what’s ahead.#EZZ #ASX

EZZ Life Science Holdings inks global distribution deal with Aumake for co-developed products buff.ly/KxlSN7f #ASX #Health $EZZ @EZZLifeScience

EZZ serves up Australian Open action to Chinese and Southeast Asian tennis fans buff.ly/RYC81lA #ASX #Health $EZZ @EZZLifeScience

We’re thrilled to welcome Mr Gary Liu as our Non-Executive Chair, bringing his APAC capital markets and listed company expertise to fuel EZZ’s global growth👏🏻 Read more: cdn-api.markitdigital.com/apiman-gateway…

$EZZ 's former Chair Glenn Cross is moving to Chief Strategy Officer. 40+ years in life sciences, Glenn will help EZZ deliver on its strategic priorities. Read more: cdn-api.markitdigital.com/apiman-gateway…

$EZZ is thrilled to be back at the 2025 China International Import Expo (@ciieonline) this week, our 6th consecutive year at this key global trade event! 🎉 Excited to connect with partners, friends and consumers.

ASX Health Quarterly Wrap: with @RaceOncology @EZZLifeScience @NeurotechInt showing progress on multiple fronts, with a strong start to FY26 buff.ly/Ra8viT8 #ASX #Health $RAC $EZZ $NTI

Australia’s ageing neighbours are driving a booming “silver economy.” $EZZ is well positioned in healthy ageing and longevity solutions across Asia where demand is accelerating fast. theaustralian.com.au/business/stock…

The US$2T US wellness market is booming. ASX-listed @EZZLifeScience is jumping in with EZZDAY, its US brand of science-backed, FDA-approved supplements made for America’s wellness craze: buff.ly/8XkYf3s #ASX #Health $EZZ

$EZZ is pleased to release its Appendix 4C for the quarter ending 30 June 2025. Customer receipts were $21.3m, up 46% on the previous quarter. The company generated $1.4m in positive cash flow and ended the quarter with $20.8m in cash. $EZZ.ax READ MORE: cdn-api.markitdigital.com/apiman-gateway…

EZZ Life Sciences taps University of Sydney for bone growth supplement research buff.ly/cXTSeVb #ASX #health $EZZ @EZZLifeScience

$EZZ has entered into a research services agreement with the University of Sydney on a two-year study into a novel multi-ingredient supplement for bone growth. More here: theaustralian.com.au/business/stock…

$EZZ Chair Glenn Cross shares an update on the recently signed a distribution agreement with ROFA Enterprises for the introduction of the EZZ brand into Southeast Asia, with a minimum purchase commitment of $21 million over three years. $EZZ.ax #ASX200 #AusBiz

Tina Sun, EZZ’s Global Marketing Head, shares insights on the Company's US launch and the four new products under the #EZZDAY brand — from FDA compliance to supplier selection. $EZZ $EZZ.ax

EZZ targets global growth with supplement push. More here: sharecafe.com.au/2025/06/20/ezz…

Break it Down: @EZZLifeScience launches EZZDAY brand in US with four dietary supplements, watch now: buff.ly/JfZnQPL #ASX #health $EZZ

EZZ and these ASX stocks ride China’s growing kids supplement boom buff.ly/L2Iydvj #ASX #health $EZZ @EZZLifeScience

Join $EZZ Life Science Holdings Chair Glenn Cross for @sharecafetweets upcoming Sip and Learn webinar on 19 June. EZZ will provide an update on its international expansion and strategic progress. Register for free: sharecafe.com.au/sip-learn/

@Mufasa_Capital Unfortunately not. Please email ir@ezzlife.com.au and we may be able to send you a transcript.

@EZZLifeScience Hi, do you have a video recording of this webinar please?

$EZZ will release its FY25 half-year results tomorrow (26 Feb 2025). Chair Glenn Cross & CFO Tony Guarna will host an investor webinar at 2 PM ADST to discuss the results. Register for the webinar here: us06web.zoom.us/webinar/regist…